1)chemotherapeutic effect化疗疗效
1.The retrospective study was performed to elucidate the chemotherapeutic effect, so as to analyze its probable prognostic factors.目的：分析晚期食管癌的化疗疗效，并探讨影响预后的因素。
2)chemotherapy response化疗疗效
1.Results The serum TSGF levels in malignant tumor patients were significantly higher than those of normal controls,and it was closely related to diagnosis and chemotherapy response of malignant tumor.目的 通过检测恶性肿瘤患者及比较其化疗前后血清TSGF水平 ,探讨TSGF在恶性肿瘤诊断中的价值及与化疗疗效的关系。
3)Chemotherapy[英][,ki:m??'θer?pi][美]['kimo'θ?r?p?]化疗疗效
1.Analysis of the Relationship Between the Chemotherapy Effects of Metastatic Breast Cancer and the Histological Grade,Biological Indicators;转移性乳腺癌化疗疗效与组织学分级、生物学指标C-erbB-2等相关性分析
4)chemosensitization化疗增效
1.Experiment of advancing chemosensitization of Etoposide by insulin in vitro;结论:在体外,胰岛素可诱导人乳腺癌细胞株MBA-MD-543增殖,胰岛素对Vp-16有一定的化疗增效作用,其用药时机和浓度的选择是实现增效的关键。
英文短句/例句
1.Insulin-induced Enhancement of 5-fluorouracil Chemotherapeutic Response and Its Mechanism;胰岛素对5-氟尿嘧啶化疗增效作用及其机制
2.The Effect of EGF Chemotherapeutic Drug Sensitivity in Colo26 and Hep-2 Cancer Cells;EGF对癌细胞Colo26、Hep-2化疗增效作用的研究
3.Clinical Study on Tumor Treated With Huangqi Injection Combined With Chemotherapy;黄芪注射液辅助化疗增效减毒的临床研究
4.The Effect of Insulin on Chemotherapeutic Drug Sensitivity in Human Breast Cancer Cell Line in Vitro;胰岛素对人乳腺癌细胞株化疗增效作用的体外研究
5.Clinical Study of ZhongLiuKang Capsule on Raising Efficiency and Reducing Toxicity during Chemotherapy in the Middle-late Stage of Non-Small Cell Lung Cancer;肿瘤康胶囊对中晚期非小细胞肺癌化疗增效减毒的临床研究
6.Clinical observasion on synergic effect of hyperthermia to chemotherapy热疗对恶性肿瘤化疗的增效作用观察
7.Therapeutic Effect Observation of Liver-Dredging and Stasis-Dispersing Method to Mesangial Proliferative Glomerulonephritis;疏肝化瘀法治疗系膜增生性肾炎疗效观察
8.The Role of Dynamic Contrast-enhanced MRI for Evaluating Therapeutic Effect for NSCLC Patients with Chemotherapy or Chemoradiotherapy动态增强MRI对NSCLC放化疗疗效评价的研究
9.Clinical Observation on Lung Cancer with Feian Mixture Combined with Chemotherapy;肺安颗粒对肺癌化疗减毒增效作用的临床研究
10.Chemosensitivity Effects and Mitochondria Mechanisms Study on the Human Lung Adenocarcinoma Cell Line A549;肺腺癌化疗药物增敏效应及线粒体机制研究
11.Study on the Isolation and Determination of Polysaccharides in a Chinese Herbs Complex Prescription Used in Malignant Tumor Chemotherapy to Attenuate Adverse Effect and Enhance Curative Effect;恶性肿瘤化疗减毒增效复方中药中多糖的研究
12.Synergism and Attenuation Effects of Taurine on Tumor Bearing Mice Treated with Chemotherapy牛磺酸对化疗荷瘤小鼠增效减毒作用的研究
13.Synergy and Attenuation Action of Gankangling Capsules on Chemotherapeutics肝康灵胶囊对化疗药物的增效减毒作用研究
14.The clinical trial about the attenuation and synergistic effect of Haishengsu海生素对化疗减毒和增效作用的临床研究
15.Synergistic Effects and Decreasing Toxicity of Sarcandra Glabra Essential Oils on Tumor-bearing Mice Treated by Cytoxan肿节风挥发油对荷瘤小鼠化疗的增效减毒作用
16.Growth Suppression and Chemosensitivity of Lung Cancer Cells Induced by Recombinant Adenovirus Expressing ING4 and hIL-24 in VitroAd-ING4-IRES-IL-24对肺癌细胞抑癌增效和化疗增敏的体外实验研究
17.A Clinical Study on Yifeizengxiao Decoction Combined with Chemotherapy in the Treatment of Intermediate and Advanced Non-Small Cell Lung Cancer;益肺增效汤联合化疗治疗中晚期非小细胞肺癌的临床研究
18.The Clinical Therapeutic Evaluation on the Transurethral Bi-polar Vaporization of the Prostate among High Risk Patients;经尿道双极电汽化切除术治疗高危前列腺增生症的疗效评价
相关短句/例句
chemotherapy response化疗疗效
1.Results The serum TSGF levels in malignant tumor patients were significantly higher than those of normal controls,and it was closely related to diagnosis and chemotherapy response of malignant tumor.目的 通过检测恶性肿瘤患者及比较其化疗前后血清TSGF水平 ,探讨TSGF在恶性肿瘤诊断中的价值及与化疗疗效的关系。
3)Chemotherapy[英][,ki:m??'θer?pi][美]['kimo'θ?r?p?]化疗疗效
1.Analysis of the Relationship Between the Chemotherapy Effects of Metastatic Breast Cancer and the Histological Grade,Biological Indicators;转移性乳腺癌化疗疗效与组织学分级、生物学指标C-erbB-2等相关性分析
4)chemosensitization化疗增效
1.Experiment of advancing chemosensitization of Etoposide by insulin in vitro;结论:在体外,胰岛素可诱导人乳腺癌细胞株MBA-MD-543增殖,胰岛素对Vp-16有一定的化疗增效作用,其用药时机和浓度的选择是实现增效的关键。
5)chemotherapeutic efficacy化疗效果
1.Purpose To explore the relationship between expression of apoptosis modulating proteins and chemotherapeutic efficacy in acute leukemia.目的 观察凋亡调节蛋白的表达与急性白血病化疗效果的关系。
6)evaluation of chemoth化疗疗效评估
延伸阅读
肿瘤化疗疗效评定标准肿瘤化疗疗效评定标准 一般采用世界卫生组织(WHO)所颁布的有关实体瘤化学治疗的疗效准标，其标准如下：(一)可测量的病变：①完全缓解：(complete remission，CR)：可见的肿瘤病变完全消失，维持4周以上；②部分缓解(partial remission，PR)：肿瘤病灶的最大直径及其最大的垂直横径的乘积缩小50%以上，其他病灶无增大，无新病灶出现，维持4周以上；③稳定(stable disease，SD)或无变化(no change，NC)：肿瘤病灶的两径乘积缩小不足50%，或增大不超过25%，无新病灶出现，维持4周以上；④进展(progression disease，PD)：肿瘤病灶的两径乘积增大25%以上或出现新病灶。此标准对肿瘤大小的测量为双径乘积的治疗前后对比。(二)不可测量的病变：①CR：所有的症状、体征完全消失至少4周；②PR：估计肿瘤大小减少50%或＞50%，至少4周；③NC：病情无明显变化至少4周，估计肿瘤大小减少不足50%，增大不到25%；④PD：有新病变出现，或原有病变估计增大25%或超过25%。(三)骨转移的疗效评价标准：①CR：X线或核素扫描等检查，原有病变完全消失，持续4周以上；②PR：溶骨性病灶部分缩小、钙化或成骨病变之密度减低，持续4周以上；③NC：病变无明显变化，由于骨病变之变化往往较缓慢，所以判定NC至少在开始治疗的第8周后；④PD：原有病灶扩大及(或)出现新病灶。凡有骨折、压缩性骨折及其愈合情况，不作为评价骨转移疗效的单一指标。(四)癌性渗出液(胸腹水)的疗效评价标准：CR：渗出液消失，癌细胞阴性，持续4周以上。PR：渗出液显著减少，癌细胞阴性，持续4周以上。NC：未达到上述指标。近期疗效中以CR+PR为有效，其占可评价病例的百分率为有效率；有效率中又可分为CR率和PR率。SD或NC及PD为无效。远期疗效的评价主要包括生存时间与生活质量，生存时间评价以平均生存期，中位生存期，生存率表示。生存率按观察时间又分为半年生存率，1年生存率，2年生存率，3年生存率，5年生存率及10年生存率。按生存质量又分为无病生存率或无复发生存率。
